We were delighted to meet with Jose Gonzalez-Juanatey to discuss the REALITY clinical trial investigating one-year major cardiovascular events after restrictive Vs liberal blood transfusion strategy among patients with acute myocardial infarction and anemia: and the potential impact on future clinical practice.
Questions:
- An overview of the REALITY clinical trial (00:06)
- What impact might these findings have on clinical practice? (05:34)
Speaker disclosures: Jose Gonzalez-Juanatey has received research grants from: Boehringer-Ingelheim, Novartis, Bayer, AstraZeneca, and been a speaker or consultant to: Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Bristol Myers Squibb, Daichii-Sankyo, Ferrer International, Novo Nordisk, Novartis, Pfizer, Sanofi, Servier.
Support: Interview and filming supported by Touch Medical Media and conducted by Nicola Cartridge.
Filmed during a remote video call with Professor Jose Gonzalez-Juanatey as a highlight of ACC 2021, May 2021.
